Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T10:26:21.188Z Has data issue: false hasContentIssue false

Brain natriuretic peptide level in a small series of children and grown-ups with congenital heart defects with chronic cardiac failure

Published online by Cambridge University Press:  09 July 2012

Giorgia Grutter*
Affiliation:
Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
Sara Alfieri
Affiliation:
Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
Francesco Parisi
Affiliation:
Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
*
Correspondence to: Dr G. Grutter, Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant' Onofrio 4, 00100 Rome, Italy. Tel: +30 06 68593731; Cell: +39 3395450030; Fax: +39 06 68592607; E-mail: giorgiagrutter@libero.it
Rights & Permissions [Opens in a new window]

Abstract

The present study assessed the usefulness of brain natriuretic peptide in evaluating the cardiovascular status in children and grown-ups with congenital or acquired disease affected by chronic cardiac failure. Brain natriuretic peptide should be included in the risk stratification of children with dilated cardiomyopathy. In patients with congenital heart defects, it is useful to tailor the optimal medical strategy to individual patients.

Information

Type
Brief Reports
Copyright
Copyright © Cambridge University Press 2012 
Figure 0

Figure 1Three-dimensional echocardiogram study for resynchronisation therapy in a child with dilated cardiomyopathy-associated long QT syndrome.

Figure 1

Table 1